Back to search results

Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy

Abroad (travel likely)Recruiting

Conditions

Lymphoma · Leukemia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Children s Hospital of Los Angeles, Los Angeles, California, United States

    Contact: Study coordinator (Ashley Whitaker, Ph.D., ABPP-CN) · awhitaker@chla.usc.edu · (323) 361-2744

  • National Institutes of Health Clinical Center, Bethesda, Maryland, United States

    Contact: Study coordinator (For more information at the NIH Clinical Center contact National Cancer Institute Referral Office) · 888-624-1937

  • Seattle Children s Hospital, Seattle, Washington, United States

    Contact: Study coordinator (Juliane Gust, M.D., Ph.D.) · Juliane.Gust@seattlechildrens.org · 296-330-7728
Study leads

  • Pamela L Wolters, Ph.D.

    Principal Investigator

    National Cancer Institute (NCI)

View source on ClinicalTrials.gov(opens in a new tab)